Loading
A phase 2 trial of Zelenectide pevedotin in non-small-cell lung cancer and small-cell lung cancer, run by BicycleTx Limited, active and no longer recruiting.
Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer is a phase 2 interventional study registered as NCT06933329 by BicycleTx Limited, with 73 participants planned, started 2025-07-18 and due to reach its primary completion in 2028-08-31. Interventions recorded: Zelenectide pevedotin. Conditions listed: Non-Small Cell Lung Cancer. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Zelenectide pevedotin, Bicycle Therapeutics, Peptide-drug & small-molecule-drug conjugates.
Shares Zelenectide pevedotin, Bicycle Therapeutics, Peptide-drug & small-molecule-drug conjugates.
Shares Zelenectide pevedotin, Bicycle Therapeutics, Peptide-drug & small-molecule-drug conjugates, Non-small-cell lung cancer.
Shares Bicycle Therapeutics, Small-cell lung cancer, Non-small-cell lung cancer.
Shares Zelenectide pevedotin, Peptide-drug & small-molecule-drug conjugates.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/